Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 4 boards, counting each seat separately. Longest: Dyne Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Dyne Therapeutics Inc. June 5, 202691.5%
-
Vor Biopharma Inc. May 26, 202399.9%
-
Dyne Therapeutics Inc. May 24, 202376.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 7, 2026 | Braveheart Bio Inc. | Open-market purchase | +55,555 | $18.00 | $999,990 |
| Apr 24, 2026 | Dyne Therapeutics Inc. | Gift | −53,625 | — | — |
Questions about David Charles Lubner
What boards is David Charles Lubner on?
David Charles Lubner sits on the boards of Braveheart Bio Inc., Crescent Biopharma Inc., Dyne Therapeutics Inc. and Vor Biopharma Inc.
How long has David Charles Lubner served on boards?
Our records show at least 9 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.